These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 5736056)

  • 1. [Liver clearance of bromosulphalein (BSF) in cirrhosis].
    Rodés J; Bordas JM; Bruguera M; Terés J
    Rev Clin Esp; 1968 Nov; 111(3):303-14. PubMed ID: 5736056
    [No Abstract]   [Full Text] [Related]  

  • 2. [Test of the resorption of B.S.P. in ascites].
    Toulet J; Pichard J; Pagniez R
    Rev Int Hepatol; 1968; 18(4):591-6. PubMed ID: 5688214
    [No Abstract]   [Full Text] [Related]  

  • 3. [The BSP purification tests].
    Chevrel B
    Presse Med (1893); 1969 Apr; 77(18):682. PubMed ID: 5790092
    [No Abstract]   [Full Text] [Related]  

  • 4. [Liver tests. I. Liver function tests using radioisotope labelled dyes].
    Zeidler U; Nuić M; Reblin T; Bär U
    Radiol Diagn (Berl); 1971; 12(6):749-61. PubMed ID: 5147017
    [No Abstract]   [Full Text] [Related]  

  • 5. [Semiological value of the disappearance curve of plasma bromosulphalein, taken at short intervals; kinetics of this dye].
    Valtueña JP; Calvo del Olmo T; De Castro del Pozo S
    Rev Esp Enferm Apar Dig; 1970 May; 31(4):351-74. PubMed ID: 5490521
    [No Abstract]   [Full Text] [Related]  

  • 6. [Triglyceridemia in liver cirrhosis].
    Swynghedauw B
    Ann Biol Clin (Paris); 1971; 29(5):393-6. PubMed ID: 5145639
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: High-dose bromsulphalein clearance test.
    Sereny G; Kalant H; Endrenyi L
    J Med; 1973; 4(3):193-4. PubMed ID: 4520759
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analysis of the BSF plasma clearance curve, using compartmental models].
    Molino G; Milanese M
    Boll Soc Ital Biol Sper; 1974 Oct; 50(20):1668-73. PubMed ID: 4464014
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bromosulphalein clearance in the elderly].
    Tuchszer S; Levin H; Fiszlejder L; Schcolnicov B; Rigilo R; Kramer FO
    Prensa Med Argent; 1969 Sep; 56(29):1437-41. PubMed ID: 5381884
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thrombocytopenia and liver cirrhosis].
    Frick W
    Schweiz Med Wochenschr; 1967 Apr; 97(13):407-13. PubMed ID: 4174227
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and chemical course control of liver cirrhosis].
    Strohmeyer G; Dölle W; Martini GA
    Fortschr Med; 1973 Oct; 91(29):1140-4. PubMed ID: 4270664
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical problems of alcoholic cirrhosis. III. Laboratory findings, reliability limits and sensitivity in patients with liver cirrhosis in various phases of the disease].
    Knezević S; Wulfe HR; Kneźevic S; Madarić M; Falisevac V
    Acta Med Iugosl; 1976; 30(5):469-81. PubMed ID: 1015348
    [No Abstract]   [Full Text] [Related]  

  • 13. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C; Brissot P; Messner M; Delamaire D; Gie S; Bourel M
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):1-6. PubMed ID: 6529154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [B.S.P. in the diagnosis of chronic diffuse anicteric liver diseases].
    Benages Martinez A; Garcia Civera R; Garcia-Conde FJ; Lopez Merino V
    Rev Esp Enferm Apar Dig; 1969 Apr; 28(4):473-90. PubMed ID: 5349869
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative evaluation of tolerance tests with sulfobromophthalein and with galactose in chronic liver diseases. (Value and limitations of the discriminating analyses used in the 2 tests for diagnosis of hepatic cirrhosis)].
    Coltorti M; Di Simone A; Budillon G; Carrella M; Oriani G
    Policlinico Med; 1968; 75(4):189-215. PubMed ID: 5708459
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical problems of alcoholic cirrhosis. IV. Various phases of liver cirrhosis and reliability limits of laboratory analyses performed in such phases].
    Knezević S; Wulff HR; Knezević S; Madarić M; Falisevac V
    Acta Med Iugosl; 1976; 30(5):483-96. PubMed ID: 1015349
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tolerance of galactose and bromsulfthalein in liver cirrhosis. A comment to a reply].
    Järnerot G
    Nord Med; 1971 Mar; 85(11):351-2. PubMed ID: 5553213
    [No Abstract]   [Full Text] [Related]  

  • 18. Biliary excretion of sulfobromophthalein sodium in patients with cholestasis and cirrhosis.
    Morgante PE; Royer M; Colombato LO
    Acta Gastroenterol Latinoam; 1971; 3(3):135-8. PubMed ID: 5157222
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatic clearence of bromosulphalein (BSF) in jaundice].
    Bordas JM; Bruguera M; Rodes J; Teres J
    Rev Esp Enferm Apar Dig; 1969 Jan; 28(1):57-92. PubMed ID: 4884768
    [No Abstract]   [Full Text] [Related]  

  • 20. The discriminant diagnostic power of liver function tests in hepatic cirrhosis.
    Serra MA; Rodrigo JM; Guix J; Montes F; Wassel A; Aparisi L; Olmo JA; Bixquert M
    Acta Med Port; 1981; 3(1):3-10. PubMed ID: 7304266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.